Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Modular Medical Inc (NQ: MODD )

2.300 +0.060 (+2.68%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Modular Medical Inc

< Previous 1 2 3 4 Next >
Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1
Via ACCESSWIRE
Modular Medical Announces Issuance of U.S. Patent Covering Key Aspects of Core Pumping Technology
Via ACCESSWIRE
Modular Medical Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the MODD1 Platform
Via ACCESSWIRE
Registration Is Now Open For Tribe Public's Webinar Event "Diabetes, Obesity, GLP-1, & The MODD-1 Opportunity" Featuring Modular Medical CEO On Wednesday, September 11, 2024
Via ACCESSWIRE
Growth Stocks Across Multiple Sectors-Innovators in Action: MODD, INBS, RCAT, KAVL, WHLR”
Via AB Newswire
Exposures Product Safety
Why Is Modular Medical Stock Up Today?
Modular Medical shares are trading higher Thursday after the company announced it has received U. S. Food and Drug Administration (FDA) clearance to market and sell its MODD1 pump in the United... 
Via Benzinga
Modular Medical Announces FDA Clearance of the MODD1 Insulin Pump
Via ACCESSWIRE
Why Modular Medical Shares Are Trading Higher By Around 29%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Modular Medical Announces Conference Call to Discuss FDA Clearance of the MODD1 Insulin Pump
Via ACCESSWIRE
MODD Stock Earnings: Modular Medical Beats EPS for Q1 2025
MODD stock results show that Modular Medical beat analyst estimates for earnings per share the first quarter of 2025. 
Via InvestorPlace
Registration is Now Open for Tribe Public’s Webinar Event "Diabetes Care Innovator Modular Medical Takes Next Steps" Featuring Modular Medical CEO on Friday, August 9, 2024
Via ACCESSWIRE
Modular Medical Initiates Transfer of Manufacturing Operations to Phillips Medisize
Via ACCESSWIRE
Modular Medical Announces Proof-of-Concept Study for Personalized Metabolic Therapy utilizing the MODD1 Platform
Via ACCESSWIRE
MODD Stock Earnings: Modular Medical Beats EPS for Q4 2024
MODD stock results show that Modular Medical beat analyst estimates for earnings per share the fourth quarter of 2024. 
Via InvestorPlace
Modular Medical Announces Addition to the Russell Microcap(R) Index
Via ACCESSWIRE
Modular Medical to Present at the Lytham Partners Spring 2024 Investor Conference on May 30
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Modular Medical Announces Steve Gemmell as New Vice President of Engineering
Via ACCESSWIRE
Registration Is Now Open for Tribe Public's Webinar Event "Revolutionizing Diabetes Care" Featuring Modular Medical CEO on Wednesday, March 6, 2024
Via ACCESSWIRE
BioMedNewsBreaks – Modular Medical Inc. (NASDAQ: MODD) Announces Pricing of $10M Public Offering
Via Investor Brand Network
Modular Medical Announces Closing of $10 Million Public Offering
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Modular Medical Announces Pricing of $10 Million Public Offering
Via ACCESSWIRE
Modular Medical Announces Proposed Public Offering
Via ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Modular Medical Announces Issuance of New US Patent
Via ACCESSWIRE
Modular Medical Announces 510(k) Submission of MODD1 Insulin Pump
Via ACCESSWIRE
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.